Qingguo Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qingguo Xie has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Dale O. Kiesewetter
National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health
2 shared publicationsGang Niu
National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health
2 shared publicationsLixin Lang
National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health
2 shared publicationsNing Guo
National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health
2 shared publicationsPeng Xiao
Department of Biomedical Engineering, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China
2 shared publications- Xiaoyuan Chen
Center for Nuclear Medicine and Molecular Imaging, Shandong Cancer Hospital and Institute, Jinan, China
2 shared publications
Latest Publications
- Top Cited Papers
- 2 October 2017
- Published by Springer Nature in Nature Photonics
- Vol. 11 (11) , 726-732
Cs2AgBiBr6 single-crystal X-ray detectors with a low detection limit
- 2 October 2017
- Published by Springer Nature in Nature Photonics
- Vol. 11 (11) , 726-732
Top Cited PapersCs2AgBiBr6 single-crystal X-ray detectors with a low detection limit
- 30 June 2016
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 61 (14) , 5390-5405
Multi-resolution multi-sensitivity design for parallel-hole SPECT collimators
Multi-resolution multi-sensitivity (MRMS) collimator offering adjustable trade-off between resolution and sensitivity, can make a SPECT system adaptive. We propose in this paper a new idea for MRMS design based on, for the first time, parallel-hole collimators for clinical SPECT. Multiple collimation states with varied resolution/sensitivity trade-offs can be formed by slightly changing the collimator's inner structure. To validate the idea, the GE LEHR collimator is selected as the design prototype and is modeled using a ray-tracing technique. Point images are generated for several states of the design. Results show that the collimation states of the design can obtain similar point response characteristics to parallel-hole collimators, and can be used just like parallel-hole collimators in clinical SPECT imaging. Ray-tracing modeling also shows that the proposed design can offer varied resolution/sensitivity trade-offs: at 100 mm before the collimator, the highest resolution state provides 6.9 mm full width at a half maximum (FWHM) with a nearly minimum sensitivity of about 96.2 cps MBq−1, while the lowest resolution state obtains 10.6 mm FWHM with the highest sensitivity of about 167.6 cps MBq−1. Further comparisons of the states on image qualities are conducted through Monte Carlo simulation of a hot-spot phantom which contains five hot spots with varied sizes. Contrast-to-noise ratios (CNR) of the spots are calculated and compared, showing that different spots can prefer different collimation states: the larger spots obtain better CNRs by using the larger sensitivity states, and the smaller spots prefer the higher resolution states. In conclusion, the proposed idea can be an effective approach for MRMS design for parallel-hole SPECT collimators.
- 30 June 2016
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 61 (14) , 5390-5405
Multi-resolution multi-sensitivity design for parallel-hole SPECT collimators
Multi-resolution multi-sensitivity (MRMS) collimator offering adjustable trade-off between resolution and sensitivity, can make a SPECT system adaptive. We propose in this paper a new idea for MRMS design based on, for the first time, parallel-hole collimators for clinical SPECT. Multiple collimation states with varied resolution/sensitivity trade-offs can be formed by slightly changing the collimator's inner structure. To validate the idea, the GE LEHR collimator is selected as the design prototype and is modeled using a ray-tracing technique. Point images are generated for several states of the design. Results show that the collimation states of the design can obtain similar point response characteristics to parallel-hole collimators, and can be used just like parallel-hole collimators in clinical SPECT imaging. Ray-tracing modeling also shows that the proposed design can offer varied resolution/sensitivity trade-offs: at 100 mm before the collimator, the highest resolution state provides 6.9 mm full width at a half maximum (FWHM) with a nearly minimum sensitivity of about 96.2 cps MBq−1, while the lowest resolution state obtains 10.6 mm FWHM with the highest sensitivity of about 167.6 cps MBq−1. Further comparisons of the states on image qualities are conducted through Monte Carlo simulation of a hot-spot phantom which contains five hot spots with varied sizes. Contrast-to-noise ratios (CNR) of the spots are calculated and compared, showing that different spots can prefer different collimation states: the larger spots obtain better CNRs by using the larger sensitivity states, and the smaller spots prefer the higher resolution states. In conclusion, the proposed idea can be an effective approach for MRMS design for parallel-hole SPECT collimators.
- 21 September 2015
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 60 (19) , 7779-7804
New approach for simultaneous respiratory and cardiac motion correction in cardiac PET (NAMC-CPET)
Respiratory and cardiac motions are inevitable during the relatively long acquisition time of cardiac positron emission tomography (PET) scan. The correction of the resultant motion blur has become a significant challenge due to recent spatial resolution improvement of the PET scanners. The majority of current motion compensation algorithms are based on gating as a primary step. A new approach based on temporal basis functions is developed to correct respiratory and cardiac motion simultaneously in cardiac PET within the normal scanning time (NAMC-CPET). Simulation and experimental studies are conducted to evaluate and validate the final outputs in comparison to the existing gating methods. A dynamic digital phantom is used to simulate realistic human thorax and abdomen with respiratory and cardiac motions. GATE simulation was run at China National Grid Center to obtain realistic PET data in a reasonable time. Moreover, Tibet minipig experiments were conducted using a preclinical small animal PET scanner developed at HUST to validate the performance of the NAMC-CPET in real data. The results reveal that NAMC-CPET outperformed the existing gating methods (respiratory, cardiac, and dual) in cardiac imaging in term of noise reduction and contrast, especially in short acquisition duration. NAMC-CPET obtained better results in the conducted experiments in terms of contrast and the visibility of the heart. In contrast, the dual gating failed to obtain valuable images in the normal scan time due to the low 18F-FDG uptake. NAMC-CPET is advantageous in the low-statistic situation. The results are promising with great potential implications in cardiac PET imaging in terms of the radioactive dose and scan time reduction.
- 21 September 2015
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 60 (19) , 7779-7804
New approach for simultaneous respiratory and cardiac motion correction in cardiac PET (NAMC-CPET)
Respiratory and cardiac motions are inevitable during the relatively long acquisition time of cardiac positron emission tomography (PET) scan. The correction of the resultant motion blur has become a significant challenge due to recent spatial resolution improvement of the PET scanners. The majority of current motion compensation algorithms are based on gating as a primary step. A new approach based on temporal basis functions is developed to correct respiratory and cardiac motion simultaneously in cardiac PET within the normal scanning time (NAMC-CPET). Simulation and experimental studies are conducted to evaluate and validate the final outputs in comparison to the existing gating methods. A dynamic digital phantom is used to simulate realistic human thorax and abdomen with respiratory and cardiac motions. GATE simulation was run at China National Grid Center to obtain realistic PET data in a reasonable time. Moreover, Tibet minipig experiments were conducted using a preclinical small animal PET scanner developed at HUST to validate the performance of the NAMC-CPET in real data. The results reveal that NAMC-CPET outperformed the existing gating methods (respiratory, cardiac, and dual) in cardiac imaging in term of noise reduction and contrast, especially in short acquisition duration. NAMC-CPET obtained better results in the conducted experiments in terms of contrast and the visibility of the heart. In contrast, the dual gating failed to obtain valuable images in the normal scan time due to the low 18F-FDG uptake. NAMC-CPET is advantageous in the low-statistic situation. The results are promising with great potential implications in cardiac PET imaging in terms of the radioactive dose and scan time reduction.
- 28 August 2013
- Published by Springer Nature in Molecular Imaging and Biology
- Vol. 16 (2) , 274-283
Comparison of Three Dimeric 18F-AlF-NOTA-RGD Tracers
RGD peptide-based radiotracers are well established as integrin αvβ3 imaging probes to evaluate tumor angiogenesis or tissue remodeling after ischemia or infarction. In order to optimize the labeling process and pharmacokinetics of the imaging probes, we synthesized three dimeric RGD peptides with or without PEGylation and performed in vivo screening. Radiolabeling was achieved through the reaction of F-18 aluminum–fluoride complex with the cyclic chelator, 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA). Three imaging probes were synthesized as 18F-AlF-NOTA-E[c(RGDfK)]2, 18F-AlF-NOTA-PEG4-E[c(RGDfK)]2, and 18F-AlF-NOTA-E[PEG4-c(RGDfk)]2. The receptor binding affinity was determined by competitive cell binding assay, and the stability was evaluated by mouse serum incubation. Tumor uptake and whole body distribution of the three tracers were compared through direct tissue sampling and PET quantification of U87MG tumor-bearing mice. All three compounds remained intact after 120 min incubation with mouse serum. They all had a rapid and relatively high tracer uptake in U87MG tumors with good target-to-background ratios. Compared with the other two tracers, 18F-AlF-NOTA-E[PEG4-c(RGDfk)]2 had the highest tumor uptake and the lowest accumulation in the liver. The integrin receptor specificity was confirmed by co-injection of unlabeled dimeric RGD peptide. The rapid one-step radiolabeling strategy by the complexation of 18F-aluminum fluoride with NOTA-peptide conjugates was successfully applied to synthesize three dimeric RGD peptides. Among the three probes developed, 18F-AlF-NOTA-E[PEG4-c(RGDfk)]2 with relatively low liver uptake and high tumor accumulation appears to be a promising candidate for further translational research.
- 28 August 2013
- Published by Springer Nature in Molecular Imaging and Biology
- Vol. 16 (2) , 274-283
Comparison of Three Dimeric 18F-AlF-NOTA-RGD Tracers
RGD peptide-based radiotracers are well established as integrin αvβ3 imaging probes to evaluate tumor angiogenesis or tissue remodeling after ischemia or infarction. In order to optimize the labeling process and pharmacokinetics of the imaging probes, we synthesized three dimeric RGD peptides with or without PEGylation and performed in vivo screening. Radiolabeling was achieved through the reaction of F-18 aluminum–fluoride complex with the cyclic chelator, 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA). Three imaging probes were synthesized as 18F-AlF-NOTA-E[c(RGDfK)]2, 18F-AlF-NOTA-PEG4-E[c(RGDfK)]2, and 18F-AlF-NOTA-E[PEG4-c(RGDfk)]2. The receptor binding affinity was determined by competitive cell binding assay, and the stability was evaluated by mouse serum incubation. Tumor uptake and whole body distribution of the three tracers were compared through direct tissue sampling and PET quantification of U87MG tumor-bearing mice. All three compounds remained intact after 120 min incubation with mouse serum. They all had a rapid and relatively high tracer uptake in U87MG tumors with good target-to-background ratios. Compared with the other two tracers, 18F-AlF-NOTA-E[PEG4-c(RGDfk)]2 had the highest tumor uptake and the lowest accumulation in the liver. The integrin receptor specificity was confirmed by co-injection of unlabeled dimeric RGD peptide. The rapid one-step radiolabeling strategy by the complexation of 18F-aluminum fluoride with NOTA-peptide conjugates was successfully applied to synthesize three dimeric RGD peptides. Among the three probes developed, 18F-AlF-NOTA-E[PEG4-c(RGDfk)]2 with relatively low liver uptake and high tumor accumulation appears to be a promising candidate for further translational research.
- 22 March 2012
- Published by Springer Nature in Molecular Imaging and Biology
- Vol. 14 (6) , 743-752
Quantitative Analysis and Parametric Imaging of 18F-Labeled Monomeric and Dimeric RGD Peptides Using Compartment Model
Non-invasive PET imaging with radiolabeled RGD peptides for αvβ3 integrin targeting has become an important tool for tumor diagnosis and treatment monitoring in both pre-clinical and clinical studies. To better understand the molecular process and tracer pharmacokinetics, we introduced kinetic modeling in the investigation of 18F-labeled RGD peptide monomer 18F-FP-c(RGDyK) (denoted as 18F-FPRGD) and dimer 18F-FP-PEG3-E[c(RGDyK)]2 (denoted as 18F-FPPRGD2).
- 22 March 2012
- Published by Springer Nature in Molecular Imaging and Biology
- Vol. 14 (6) , 743-752
Quantitative Analysis and Parametric Imaging of 18F-Labeled Monomeric and Dimeric RGD Peptides Using Compartment Model
Non-invasive PET imaging with radiolabeled RGD peptides for αvβ3 integrin targeting has become an important tool for tumor diagnosis and treatment monitoring in both pre-clinical and clinical studies. To better understand the molecular process and tracer pharmacokinetics, we introduced kinetic modeling in the investigation of 18F-labeled RGD peptide monomer 18F-FP-c(RGDyK) (denoted as 18F-FPRGD) and dimer 18F-FP-PEG3-E[c(RGDyK)]2 (denoted as 18F-FPPRGD2).